Clinical Trial Update: Pemvidutide (ALT-801) DDI Study in Healthy Volunteers [Phase 1]

View source ↗

Summary

Phase 1 drug-drug interaction study of Pemvidutide (ALT-801) in healthy volunteers has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nonalcoholic Steatohepatitis

Drugs mentioned

• Pemvidutide (ALT-801) (pemvidutide)

Snippet

Sponsor: Altimmune, Inc. | Conditions: NASH - Nonalcoholic Steatohepatitis | Phase 1 | Status: COMPLETED